HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

BI 186908

a MCH-R1 antagonist; structure in first source

Networked: 1 relevant articles (0 outcomes, 0 trials/studies)

Bio-Agent Context: Research Results

Heterocyclic Compounds: 198
- 1-Ring Heterocyclic Compounds
  - Pyridines: 88
    - BI 186908: 1
  - Pyridazines: 11
    - BI 186908: 1

Experts

1.	Arndt, Kirsten: 1 article (08/2015)
2.	Budzinski, Ralph: 1 article (08/2015)
3.	Heckel, Armin: 1 article (08/2015)
4.	Kley, Jörg T: 1 article (08/2015)
5.	Lehmann, Thorsten: 1 article (08/2015)
6.	Lenter, Martin: 1 article (08/2015)
7.	Lotz, Ralf R H: 1 article (08/2015)
8.	Maier, Gerd-Michael: 1 article (08/2015)
9.	Markert, Michael: 1 article (08/2015)
10.	Müller, Stephan: 1 article (08/2015)

Related Diseases

1.	Obesity 08/15/2015 - "Chronic administration of BI 186908 resulted in significant body weight reduction comparable to sibutramine in a 4 week diet-induced obesity model in rats. "
2.	Body Weight (Weight, Body) 08/15/2015 - "Chronic administration of BI 186908 resulted in significant body weight reduction comparable to sibutramine in a 4 week diet-induced obesity model in rats. "

Related Drugs and Biologics

1.	sibutramine (Meridia)